首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of Cancer Research And Clinical Oncology

Journal Of Cancer Research And Clinical Oncology杂志,由Springer Berlin Heidelberg出版,于1904年创刊,Monthly,出版语言English,ISSN:0171-5216,E-ISSN:1432-1335。

投稿咨询
Journal Of Cancer Research And Clinical Oncology
Journal Of Cancer Research And Clinical Oncology
Journal Of Cancer Research And Clinical Oncology
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.3
CiteScore
6.4
期刊收录
SCI、SCIE

Journal Of Cancer Research And Clinical Oncology(中文译名:《癌症研究与临床肿瘤学杂志》),ISSN:0171-5216,EISSN:1432-1335,是Springer Berlin Heidelberg出版的国际性学术期刊,创刊于1904年,以Monthly形式稳定发行,2026年总发文量约290篇。该刊采用非OA开放访问,学科归属为医学 - 肿瘤学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.3,2025年期刊CiteScore为6.4,2025年期刊自引率约3%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Journal Of Cancer Research And Clinical Oncology长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约1.0个月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDGERMANY (FED REP GER)、USA、Italy、South Korea、Japan、Switzerland等为核心发文国家与地区;FRIEDRICH SCHILLER UNIVERSITY OF JENAUNIVERSITY OF MUNICH、FUDAN UNIVERSITY、RUPRECHT KARLS UNIVERSITY HEIDELBERG、HELMHOLTZ ASSOCIATION、SICHUAN UNIVERSITY、UNIVERSITY OF HAMBURG等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 158 / 333

52.7

学科:ONCOLOGY SCIE Q2 166 / 333

50.3

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 160 / 328

51.4

学科:ONCOLOGY SCIE Q3 182 / 328

44.66


中国学者近期发文

1
Piezo channels in tumor

Author:Zhang, Wenxin; Dai, Liangliang; Shi, Honglei

Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2026; Vol. 152, Issue 4, pp. -. DOI: 10.1007/s00432-026-06474-0

2
Clinicopathological features and prognostic analysis of 30 patients with laryngeal and hypopharyngeal adenoid cystic carcinoma: a single-center retrospective stud

Author:Wang, Mingzhu; Zhou, Jing; Ma, Tingyao; Chen, Xiaohong

Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2026; Vol. 152, Issue 4, pp. -. DOI: 10.1007/s00432-026-06449-1

3
OLFM4 orchestrates the immunosuppressive microenvironment and drives gallbladder cancer progressio

Author:Li, Wenxin; Liu, Kun; Yang, Fan; He, Huisi; Wen, Wen

Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2026; Vol. 152, Issue 4, pp. -. DOI: 10.1007/s00432-026-06466-0

4
The efficacy and toxicity of TRT on metastatic NSCLC in patients treated with targeted therapy and chemoimmunotherap

Author:Xue, Lishan; Yao, Jinquan; Xu, Qian; Geng, Yuxin; Tang, Ning; Teng, Feifei

Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2026; Vol. 152, Issue 4, pp. -. DOI: 10.1007/s00432-026-06470-4

5
Macrophage plasticity in the osteosarcoma tumor microenvironment: opportunities and challenges for immunotherap

Author:Li, Haifeng; Liu, Chengri; Zhang, Baojian; Zhang, Yanhu; Liu, Yanqun

Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2026; Vol. 152, Issue 4, pp. -. DOI: 10.1007/s00432-026-06471-3

6
LncRNA-LINC01281 exerts anti-cancer functions via the MYC/VEGF pathway in the progression of cervical cance

Author:Zhang, Shuqian; Chen, Zhi; Quratul, Ain; Liu, Yan; Luo, Chengfang; Bai, Xiaoxu; Zhang, Song; Gao, Jiayin

Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2026; Vol. 152, Issue 4, pp. -. DOI: 10.1007/s00432-026-06454-4

7
Castleman disease arising from the pleura: a case report and literature revie

Author:Yang, Hao; Ning, Mingjie; Li, Pengyu; Qiu, Jing; Huang, Yu; Chen, Ying

Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2026; Vol. 152, Issue 4, pp. -. DOI: 10.1007/s00432-026-06473-1

8
Radiomics based on multiphasic contrast-enhanced CT combined with clinical features for differentiating hypovascular pancreatic neuroendocrine tumors and pancreatic ductal adenocarcinom

Author:Xia, Fan; Yu, Jie; Wang, Jianhua; Wang, Zhongqiu

Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2026; Vol. 152, Issue 4, pp. -. DOI: 10.1007/s00432-026-06481-1

9
Investigating the role of the Pon1-rs854560 (L55M) SNP in colorectal Cancer susceptibility (vol 151, 170,2025

Author:Wei, Xi; Qin, Rong; Yin, Liang; Iqbal, Muhammad Asad; Shaibu, Zakari; Li, Guorui; Wu, Ting

Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2026; Vol. 152, Issue 4, pp. -. DOI: 10.1007/s00432-026-06479-9

10
GALNT1 emerges as a potential therapeutic target in breast cance

Author:Li, Jiafu; Zhong, Pei; Li, Xizhuang; Huang, Rongzhi; Zhan, Zexu; Li, Jiehua; Mao, Min

Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2026; Vol. 152, Issue 3, pp. -. DOI: 10.1007/s00432-026-06448-2


在线咨询

Journal Of Cancer Research And Clinical Oncology

国际简称:J CANCER RES CLIN参考译名:癌症研究与临床肿瘤学杂志

年发文量:290 CiteScore:6.4 是否预警:否 Gold OA文章占比:63.18% 研究类文章占比:84.83%

杂志社联系方式:SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Journal Of Cancer Research And Clinical Oncology